Diazoxide infusion test in patients with single benign insulinoma.
The diazoxide infusion test (600 mg i.v. over a 1-hour period) was performed in 12 patients bearing single benign islet B-cell adenoma and in 6 normal subjects. Blood glucose, plasma insulin and glucagon concentrations were measured every 15 min during the infusion and thereafter up to 150 min. In insulinoma patients, blood glucose levels failed to increase significantly while in the control group a significant rise starting from 30 min persisted throughout the test (p less than 0.05 or less). Plasma insulin mean levels decreased significantly in normal subjects from 30 to 60 min (p less than 0.05), while they were significantly suppressed in hypoglycemic patients from 15 to 120 min (p less than 0.02). Diazoxide administration induced in the normal group a significant decrease in glucagon levels (p less than 0.02 from 30 to 150 min) whereas no such suppression occurred in patients. In our experience, insulin response to diazoxide infusion in patients with insulinoma may provide additional information for diagnosis.
D007516:Adenoma, Islet Cell / Q000175:diagnosis*; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D003981:Diazoxide; D005934:Glucagon / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D007340:Insulinoma / Q000175:diagnosis*; D007700:Kinetics; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000175:diagnosis*
D001786:Blood Glucose; D007328:Insulin; D005934:Glucagon; D003981:Diazoxide